• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2017)
Adel, M., Serya, R., Lasheen, D., Abouzid, K. (2018). Pyrrolopyrimidine: A Versatile Scaffold for Construction of Targeted Anti-cancer Agents. Journal of Advanced Pharmacy Research, 2(1), 1-19. doi: 10.21608/aprh.2017.4832
Mai Adel; Rabah A. T. Serya; Deena S. Lasheen; Khaled A A. M. Abouzid. "Pyrrolopyrimidine: A Versatile Scaffold for Construction of Targeted Anti-cancer Agents". Journal of Advanced Pharmacy Research, 2, 1, 2018, 1-19. doi: 10.21608/aprh.2017.4832
Adel, M., Serya, R., Lasheen, D., Abouzid, K. (2018). 'Pyrrolopyrimidine: A Versatile Scaffold for Construction of Targeted Anti-cancer Agents', Journal of Advanced Pharmacy Research, 2(1), pp. 1-19. doi: 10.21608/aprh.2017.4832
Adel, M., Serya, R., Lasheen, D., Abouzid, K. Pyrrolopyrimidine: A Versatile Scaffold for Construction of Targeted Anti-cancer Agents. Journal of Advanced Pharmacy Research, 2018; 2(1): 1-19. doi: 10.21608/aprh.2017.4832

Pyrrolopyrimidine: A Versatile Scaffold for Construction of Targeted Anti-cancer Agents

Article 1, Volume 2, Issue 1, January 2018, Page 1-19  XML PDF (507.11 K)
Document Type: Review Article
DOI: 10.21608/aprh.2017.4832
View on SCiNiTO View on SCiNiTO
Authors
Mai Adel email ; Rabah A. T. Serya; Deena S. Lasheen; Khaled A A. M. Abouzid
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
Abstract
Pyrrolopyrimidine derivatives comprise a class of biologically active heterocyclic compounds that are well known to play a critical role in pharmaceutical drug design and health care. The pyrrolopyrimidines serve as promising scaffolds that were found in a number of biologically active compounds including antibiotics, anti-inflammatory, anti-viral and anticancer. Researchers were inspired to develop novel pyrrolopyrimidine derivatives for the treatment of Cancer. Currently several pyrrolopyrimidines are available commercially as anticancer drugs.  The present review article offers a detailed account on the development of pyrrolopyrimidine derivatives with anticancer potential with emphasis on their activity as targeted kinase inhibitors.
Keywords
Anti-cancer; Protein kinases; Pyrrolopyrimidine
Statistics
Article View: 877
PDF Download: 1,487
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.